The 14th World Congress on Controversies in Obstetrics, Gynecology and Infertility (COGI) took place from 17 to 20 November 2011 at the Pullman Paris Montparnasse in Paris, France. The COGI congresses are specifically designed to provide an opportunity to discuss controversial topics in obstetrics, gynaecology and infertility with an emphasis on clinical solutions in cases where no agreed-upon answers or consensus exists. The congress provides clinicians with insights and scientific take-home messages that can improve treatment and solve problems in the most difficult situations.
In conjunction with COGI 2011, the Merck Serono satellite symposium titled
Controversial topics in ART: a conversation with the audience was held on 18 November. Professor Francois Olivennes, from the IVF Centre Eylau La Muette, Paris, France chaired the meeting and led a distinguished faculty in discussing some of the currently contentious issues in assisted reproductive technology (ART). Treatment discussions focused on gonadotrophin releasing hormone (GnRH) antagonist versus agonist use presented by Prof. George Griesinger from Germany, methods and sources of progesterone supplementation presented by Dr. Papanikolaou from Greece, convenience and comfort of fertility treatments, predicting patient success per cycle of stimulation and customisation of controlled ovarian stimulation (COS) presented by Dr. Nicholas Garrido from Spain.
A symposium summary can be downloaded.